Partnerships between telehealth companies and pharmaceutical giants Pfizer and Indianapolis-based Eli Lilly and Co. raise concerns about conflicts of interest and inappropriate prescribing, according to a Senate investigation released Thursday.
Sen. Todd Young of Indiana and Sen. James Lankford of Oklahoma advocated to remove the provision which, at the high end, would levy a tax of 10% on the investment earnings of philanthropic foundations with more than $5 billion in assets.
The Destination 2032 initiative—powered by a $5.5 million grant from the Eli Lilly and Co. Foundation—will fund a STEM Scholars program and STEM Future Centers.
Robbins—who initially planned a career in sports medicine—told IBJ that the company’s foray into sports work began in earnest when it printed thousands of Indianapolis maps for the 2012 Super Bowl. It has grown from there.
When RFRA threatened the state’s reputation in 2015, a group of business leaders helped negotiate a so-called “fix” that quelled most of the critics. It’s time for business leaders to step up again.
The medications still amount to around $500 per month for those without insurance—out of reach for many patients. And even for people with insurance, coverage remains uneven.
Municipal government leaders across Indiana are going pale in the face while they review budget forecasts for the next few years as a sweeping property tax relief law takes effect.
Central Indiana Corporate Partnership, Indy Chamber and the Indianapolis Urban League are partners in Business Equity for Indy, which launched in 2020 with 11 member companies. Today it has 50.
Indiana University School of Medicine researcher Jeff Dage’s years of research into biomarkers helped lead to a first-of-its-kind blood test to diagnose Alzheimer’s disease.
Like everything else related to the Indiana Fever, corporate sponsorship for the WNBA team was one thing in the B.C.C. Era (Before Caitlin Clark) and something much bigger since the sharp-shooting, precise-passing guard arrived in town.
Questions included whether the Indianapolis-based drugmaker is working to improve insurance coverage for the drug and highlighted users’ concerns about comparisons with Novo Nordisk’s Wegovy.
Syndeio Biosciences sees burgeoning potential to treat mental health and cognitive conditions, including Alzheimer’s and depression, with therapies that target the almost countless minuscule brain synapses that give people the ability to think and function.
The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other conditions because it comes in pill form, not an injection.
The Purdue University Board of Trustees on Friday unanimously approved a 50-year master plan for the school’s downtown campus that proposes more than a dozen buildings across 28 acres.
